drugset / Trial / NCT00650624

A Dose-Ranging Study Of Valdecoxib 5 Mg, 10 Mg, And 20 Mg Once Daily Versus Placebo In Patients With Osteoarthritis Of The Knee (Japan)

NCT00650624

Phase 2 Completed 416 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine the therapeutic dose range of valdecoxib by comparing the efficacy of three dosing regimens (5 mg, 10 mg and 20 mg once daily) with placebo for relief of the signs and symptoms of osteoarthritis of the knee. To assess safety and tolerability of multiple doses of valdecoxib in patients with osteoarthritis of the knee.

Timeline

Start
2003-06
Primary completion
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator valdecoxib Small molecule 5 mg Oral
Comparator valdecoxib Small molecule 10 mg Oral
Comparator valdecoxib Small molecule 20 mg Oral

Indications